These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Imaging-based Toxicity and Response Pattern Assessment Following CAR T-Cell Therapy. Smith DA; Kikano E; Tirumani SH; de Lima M; Caimi P; Ramaiya NH Radiology; 2022 Feb; 302(2):438-445. PubMed ID: 34751616 [TBL] [Abstract][Full Text] [Related]
7. Cytokine release syndrome and neurotoxicity after CD19 chimeric antigen receptor-modified (CAR-) T cell therapy. Hay KA Br J Haematol; 2018 Nov; 183(3):364-374. PubMed ID: 30407609 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of chimeric antigen receptor T cell immunotherapy in B-cell non-Hodgkin lymphoma: a systematic review and meta-analysis. Wang N; Meng Y; Wu Y; He J; Liu F Immunotherapy; 2021 Mar; 13(4):345-357. PubMed ID: 33406914 [No Abstract] [Full Text] [Related]
10. Mechanisms of immune effector cell-associated neurotoxicity syndrome after CAR-T treatment. Gu T; Hu K; Si X; Hu Y; Huang H WIREs Mech Dis; 2022 Nov; 14(6):e1576. PubMed ID: 35871757 [TBL] [Abstract][Full Text] [Related]
11. Endothelial Activation and Blood-Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells. Gust J; Hay KA; Hanafi LA; Li D; Myerson D; Gonzalez-Cuyar LF; Yeung C; Liles WC; Wurfel M; Lopez JA; Chen J; Chung D; Harju-Baker S; Özpolat T; Fink KR; Riddell SR; Maloney DG; Turtle CJ Cancer Discov; 2017 Dec; 7(12):1404-1419. PubMed ID: 29025771 [TBL] [Abstract][Full Text] [Related]
12. [Establishment of a cytokine release syndrome associated with chimeric antigen receptor T cell treatment in SCID/Beige mice model]. Shan JQ; Nan SF; Li F; Shen CY; Zhang Y Zhonghua Zhong Liu Za Zhi; 2021 Dec; 43(12):1248-1254. PubMed ID: 34915632 [No Abstract] [Full Text] [Related]
13. Chimeric antigen receptor T-cell therapy for the treatment of aggressive B-cell non-Hodgkin lymphomas: efficacy, toxicity, and comparative chimeric antigen receptor products. Hunter BD; Rogalski M; Jacobson CA Expert Opin Biol Ther; 2019 Nov; 19(11):1157-1164. PubMed ID: 31342797 [No Abstract] [Full Text] [Related]
14. Assessment and management of cytokine release syndrome and neurotoxicity following CD19 CAR-T cell therapy. Chou CK; Turtle CJ Expert Opin Biol Ther; 2020 Jun; 20(6):653-664. PubMed ID: 32067497 [No Abstract] [Full Text] [Related]
15. Associations of granulocyte colony-stimulating factor with toxicities and efficacy of chimeric antigen receptor T-cell therapy in relapsed or refractory B-cell acute lymphoblastic leukemia. Ma S; Wang Y; Qi K; Lu W; Qi Y; Cao J; Niu M; Li D; Sang W; Yan Z; Zhu F; Cheng H; Li Z; Zhao M; Xu K Cancer Immunol Immunother; 2024 Apr; 73(6):104. PubMed ID: 38630258 [TBL] [Abstract][Full Text] [Related]